Hematology in Focus sessions Sunday June 18

Meet-the-Expert Sessions | Simultaneous Sessions | Clinical Trial Update Session | Science in Progress Session | Hematology-in-Focus Sessions | Plenary Session II | Closing Ceremony & Farewell Lunch Buffet

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Auditorium

MYELOPROLIFERATIVE DISORDERS
Chair: W. Vainchenker (Institut Gustave Roussy, Paris, France)
  • ABNORMAL SIGNALING AND ROUTING OF EPO-R AND MPL CAUSED BY MUTANT JAK2
    S. Constantinescu (Ludwig Institute for Cancer Research and Christian de Duve Institute of Cellular Pathology, Brussels, Belgium)
  • FUNCTIONAL AND CLINICAL IMPACT OF THE JAK2 MUTATION
    R. Skoda (University Hospital Basel, Basel, Switzerland)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Forum

TREATMENT STRATEGIES IN FOLLICULAR LYMPHOMA
Chair: R. Marcus (Addenbrookes Hospital Cambridge, Cambridge, United Kingdom)
  • FIRST-LINE TREATMENT OF FOLLICULAR LYMPHOMA
    R. Marcus (Addenbrookes Hospital Cambridge, Cambridge, United Kingdom)
  • SHOULD PATIENTS RECEIVE MAINTENANCE THERAPY WITH RITUXIMAB?
    M. Ghielmini (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room X

CORD BLOOD HSC TRANSPLANTATION
Chair: E. Gluckman (Hôpital Saint-Louis, Paris, France)
  • DOUBLE CORD BLOOD TRANSPLANTATION
    J.E. Wagner (University of Minnesota, Minneapolis, USA)
  • ADULT CORD BLOOD TRANSPLANTATION
    W. Arcese (University of Rome "Tor Vergata", Rome, Italy)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room Y

ROLE OF EVI1 IN LEUKEMOGENESIS
Chair: S. Raynaud (University Hospital Nice, Nice, France)
  • EVI1 - SITE OF RETROVIRAL INSERTION
    Ch. Baum (Hannover Medical School, Hannover, Germany)
  • EVI1 IN THE PATHOGENESIS OF MDS AND AML
    R. Delwel (Erasmus Medical Center, Rotterdam, The Netherlands)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room A

DEVELOPMENTS IN TRANSFUSION MEDICINE
Chair: P. Rebulla (O.U. Center of Transfusion Medicine, Milan, Italy)
  • BIOLOGY AND TRANSMISSION OF PRION DISEASES
    J.W. Ironside (University of Edinburgh, Edinburgh, United Kingdom)
  • NEW APPROACHES TO PLATELET TRANSFUSIONS
    L.M. Williamson (University of Cambridge, Cambridge, United Kingdom)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room B

EXTRINSIC CONTROL OF STEM CELL FATE
Chair: W.E. Fibbe (Leiden University Medical Center, Leiden, The Netherlands)

  • STEM CELL SELF RENEWAL AND THE BONE MARROW NICHE
    T. Suda (Keio University, School of Medicine, Tokyo, Japan)
  • CYTOKINE REGULATION OF HEMATOPOIETIC STEM CELL FATE
    S.E.W. Jacobsen (Lund University, Lund, Sweden)

Top of page ]


EHA Executive Office, Westblaak 71, 3012 KE Rotterdam, The Netherlands | Phone: (+31) 10-4361760 | Email: